Showing 5,171 results

Filters Content type: Editors' picks Country: United States
HIV in the arts & media

'PrEP Play, or Blue Parachute Strong' - strong medicine needs more regimen

Editor's pick
Bay Area Reporter
21 April 2022
Activism & civil society

Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court

Editor's pick
FiercePharma
19 April 2022
Improving HIV care

New Best Practice Guide on Telehealth and HIV Care for Providers

Editor's pick
Blog
19 April 2022
Government, leadership & policy

White House’s Harold Phillips Discusses Top 5 ONAP Priorities

Editor's pick
Blog
19 April 2022
HIV prevention policy

Equity-Driven Advocacy for a National PrEP Program for Uninsured People

Editor's pick
POZ
19 April 2022
PrEP policies & guidelines

Insurers Across the US Are Often Illegally Charging for PrEP

Editor's pick
TheBody
19 April 2022
Pharmaceutical industry

Counterfeit HIV Drugs: US Justice Department Opens Investigation

Editor's pick
Medscape (requires free registration)
13 April 2022
Employment

Judge rules US military can’t discharge HIV-positive troops

Editor's pick
The Hill
11 April 2022
Coronavirus

A Rare Personal Appeal to My POZ Brothers & Sisters; Please Protect Yourself Against Covid-19

Editor's pick
AIDS Drug Assistance Program
7 April 2022
Finance & funding

Biden’s 2023 Budget Invests $9.8B in PrEP and Boosts Other HIV Funding

Editor's pick
POZ
31 March 2022
Improving HIV care

‘I’m Just Trying to Live’: Abuse and Punishment Pervade HIV Clinics

Editor's pick
TheBodyPro
31 March 2022
Injectable & long-acting HIV treatment

US: Cabenuva Approval Expanded to Include Adolescents With HIV

Editor's pick
Monthly Prescribing Reference
31 March 2022
Women

Ending HIV Criminalization Starts With Me

Editor's pick
POZ
31 March 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period

Editor's pick
ViiV press release
25 March 2022
Pregnancy and vertical transmission

ART Associated With Less Risk of Preterm Birth in Large US Study

Editor's pick
Medscape (requires free registration)
21 March 2022
Government, leadership & policy

San Francisco: In wake of COVID, advocates for HIV care seek return to spotlight

Editor's pick
San Francisco Chronicle
21 March 2022
Self-testing & home testing

Send Every American a Free Home HIV Test

Editor's pick
Slate
21 March 2022
People who inject drugs

HIV Outbreak Among Drug Users Accelerates in Boston

Editor's pick
Boston Globe
21 March 2022
Economic & social inequality

Income May Be the Biggest Determinant of Whether Women Stay on PrEP

Editor's pick
POZ
18 March 2022
HIV & criminal law

How New Jersey Became the Third U.S. State to Repeal Its HIV Criminalization Law

Editor's pick
TheBody
18 March 2022
Retention & linkage to care

Inpatient Hospital Discharges Highlight Missed Opportunities for HIV Care in People With Schizophrenia

Editor's pick
Medscape (requires free registration)
11 March 2022
History of HIV & AIDS

Queer reading: ACT UP's Staley is not silent in new book

Editor's pick
Bay Area Reporter
10 March 2022
Injectable & long-acting HIV treatment

US: Bottlenecks are slowing switch to GSK's long-acting HIV injectable Cabenuva: clinician

Editor's pick
FiercePharma
9 March 2022
Health services & systems

How to Induce Rage in a Doctor

Editor's pick
HIV and ID Observations
8 March 2022